This activity is supported by educational funding provided by AbbVie Inc.; Astellas Scientific and Medical Affairs, Inc. and Medivation; and Sanofi US.
The selection of therapy for patients with castration-resistant prostate cancer (CRPC) remains challenging. Review…
Journal of Pediatric Ophthalmology and Strabismus
Online Advanced Release, May 17, 2017
To characterize anatomical variations of the nasolacrimal canal in patients with complex congenital nasolacrimal duct…